{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:52:44Z","timestamp":1792011164660,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,8]],"date-time":"2027-10-08T00:00:00Z","timestamp":1822953600000},"content-version":"am","delay-in-days":311,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM157326"],"award-info":[{"award-number":["R35GM157326"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM130546"],"award-info":[{"award-number":["T32GM130546"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006792","name":"The Hartwell Foundation Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000997","name":"Arnold and Mabel Beckman Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2542672"],"award-info":[{"award-number":["2542672"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["T32EB006359"],"award-info":[{"award-number":["T32EB006359"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Biomedical Engineering"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cobme.2026.100682","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:13:53Z","timestamp":1789722833000},"page":"100682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design considerations for potent DNA-platform-based cancer vaccines"],"prefix":"10.1016","volume":"40","author":[{"given":"Anna Maria","family":"Ferrante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4664-420X","authenticated-orcid":false,"given":"Michelle H.","family":"Teplensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cobme.2026.100682_bib1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41568-025-00820-z","article-title":"Recent advances in therapeutic cancer vaccines","volume":"25","author":"Zaidi","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cobme.2026.100682_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102215","article-title":"Bioinspired vaccines to enhance MHC Class-I antigen cross-presentation","volume":"77","author":"Baljon","year":"2022","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.cobme.2026.100682_bib3","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1039\/D3TB01677C","article-title":"Harnessing biomaterial architecture to drive anticancer innate immunity","volume":"11","author":"Davis","year":"2023","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.cobme.2026.100682_bib4","article-title":"DNA nanostructures: advancing cancer immunotherapy","volume":"20","author":"Chen","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.cobme.2026.100682_bib5","article-title":"Targeting lymph nodes for enhanced cancer vaccination: from nanotechnology to tissue engineering","volume":"26","author":"Wang","year":"2024","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.cobme.2026.100682_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s44222-024-00161-w","article-title":"Subcutaneous drug delivery from nanoscale systems","volume":"2","author":"Tomasini","year":"2024","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.cobme.2026.100682_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46351-1","article-title":"Biodistribution and function of coupled Polymer-DNA origami nanostructures","volume":"13","author":"Joseph","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.cobme.2026.100682_bib8","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1038\/s41467-024-52104-z","article-title":"Tuning the fluidity and protein Corona of ultrasound-responsive liposomal nanovaccines to program T cell immunity in mice","volume":"15","author":"He","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.cobme.2026.100682_bib9","article-title":"DNA nanostructures as promising anticancer agents: a review","volume":"45","author":"Jafari","year":"2025","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.cobme.2026.100682_sref10","doi-asserted-by":"crossref","first-page":"15783","DOI":"10.1021\/acsami.3c18068","article-title":"Cell\u2013surface binding of DNA nanostructures for enhanced intracellular and intranuclear delivery","volume":"16","author":"Wang","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.cobme.2026.100682_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143396","article-title":"DNA based and stimuli-responsive smart nanocarrier for diagnosis and treatment of cancer: applications and challenges","volume":"13","author":"Sabir","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.cobme.2026.100682_sref12","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409555122","article-title":"Modulating antigen processing through metal\u2013organic frameworks to bias adaptive immunity","volume":"122","author":"Cho","year":"2025","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cobme.2026.100682_bib13","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1039\/D3BM01970E","article-title":"Emerging nanoparticle platforms for CpG oligonucleotide delivery","volume":"12","author":"Li","year":"2024","journal-title":"Biomater Sci"},{"key":"10.1016\/j.cobme.2026.100682_bib14","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1021\/acs.nanolett.2c00275","article-title":"Spatially controlled activation of toll-like receptor 9 with DNA-based nanomaterials","volume":"22","author":"Comberlato","year":"2022","journal-title":"Nano Lett"},{"key":"10.1016\/j.cobme.2026.100682_sref15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/s41565-024-01615-3","article-title":"Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccination","volume":"19","author":"Zeng","year":"2024","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.cobme.2026.100682_bib16","doi-asserted-by":"crossref","first-page":"13545","DOI":"10.1021\/jacs.5c00481","article-title":"Dynamic DNA-based nanoadjuvants for TLR9 clustering and innate immune activation in dendritic cells","volume":"147","author":"Lv","year":"2025","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cobme.2026.100682_sref17","article-title":"A modular DNA hydrogel vaccine with optimized nanoadjuvants and tumor targeting capacity","volume":"36","author":"Hu","year":"2026","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.cobme.2026.100682_bib18","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1039\/D5SC06966A","article-title":"Navigating the next frontier in biomedicine: Breakthroughs and insights in nucleic acid therapeutics","volume":"17","author":"Wu","year":"2026","journal-title":"Chem Sci"},{"key":"10.1016\/j.cobme.2026.100682_bib19","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3390\/ph15080909","article-title":"The medicinal chemistry of artificial nucleic acids and therapeutic oligonucleotides","volume":"15","author":"Bege","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cobme.2026.100682_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-61666-3","article-title":"Introduction of sugar-modified nucleotides into CpG-Containing antisense oligonucleotides inhibits TLR9 activation","volume":"14","author":"Yoshida","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.cobme.2026.100682_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102126","article-title":"Engineering cGAS-Agonistic oligonucleotides as therapeutics for cancer immunotherapy","volume":"35","author":"Zhou","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.cobme.2026.100682_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202400321","article-title":"2\u2019,4\u2019-LNA-Functionalized 5\u2032-S-Phosphorothioester CDNs as STING agonists","volume":"25","author":"Yeboah","year":"2024","journal-title":"Chembiochem"},{"key":"10.1016\/j.cobme.2026.100682_bib23","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1093\/nar\/gkad090","article-title":"Filament assembly underpins the double-stranded DNA specificity of AIM2-like receptors","volume":"51","author":"Garg","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cobme.2026.100682_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1050774","article-title":"AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinoma","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cobme.2026.100682_bib25","doi-asserted-by":"crossref","first-page":"24972","DOI":"10.1021\/acsnano.5c04293","article-title":"Chemical composition and backbone modifications define deformability of nucleic acid nanoparticles","volume":"19","author":"Pandey","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.cobme.2026.100682_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101262","article-title":"Spherical nucleic acid vaccine structure markedly influences adaptive immune responses of clinically-utilized prostate cancer targets","volume":"10","author":"Teplensky","year":"2021","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.cobme.2026.100682_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011651","article-title":"Phase 1b\/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with Anti-PD-1 antibodies among patients with advanced solid tumors","volume":"13","author":"Milhem","year":"2025","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.cobme.2026.100682_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1021\/acs.bioconjchem.1c00540","article-title":"An investigation into the resistance of spherical nucleic acids against DNA enzymatic degradation","volume":"33","author":"Kyriazi","year":"2022","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.cobme.2026.100682_bib29","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1021\/acs.nanolett.2c00723","article-title":"Maximizing TLR9 activation in cancer immunotherapy with dual-adjuvanted spherical nucleic acids","volume":"22","author":"Chen","year":"2022","journal-title":"Nano Lett"},{"key":"10.1016\/j.cobme.2026.100682_bib30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41551-022-01000-2","article-title":"Multi-antigen spherical nucleic acid cancer vaccines","volume":"7","author":"Teplensky","year":"2023","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.cobme.2026.100682_sref31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aec3876","article-title":"E711-19 placement and orientation dictate CD8+ T cell response in structurally defined spherical nucleic acid vaccines","volume":"12","author":"Hwang","year":"2026","journal-title":"Sci Adv"},{"key":"10.1016\/j.cobme.2026.100682_bib32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12951-022-01353-5","article-title":"Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced cancer treatment","volume":"20","author":"Deng","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.cobme.2026.100682_bib33","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1021\/acscentsci.1c00779","article-title":"Chemically tuning the antigen release kinetics from spherical nucleic acids maximizes immune stimulation","volume":"7","author":"Skakuj","year":"2021","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.cobme.2026.100682_bib34","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1021\/acs.nanolett.4c01392","article-title":"DNA anchoring strength directly correlates with spherical nucleic acid\u2013based HPV E7 cancer vaccine potency","volume":"24","author":"Hwang","year":"2024","journal-title":"Nano Lett"},{"key":"10.1016\/j.cobme.2026.100682_bib35","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409554122","article-title":"Controlling intracellular processing to enhance spherical nucleic acid immune stimulation","volume":"122","author":"Kang","year":"2025","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cobme.2026.100682_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/science.adx6291","article-title":"DNA origami vaccines program antigen-focused germinal centers","volume":"391","author":"Romanov","year":"2026","journal-title":"Science"},{"key":"10.1016\/j.cobme.2026.100682_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202315093","article-title":"A DNA origami-based gene editing system for efficient gene therapy in vivo","volume":"62","author":"Tang","year":"2023","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cobme.2026.100682_bib38","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41565-023-01443-x","article-title":"DNA-Origami-Directed virus capsid polymorphism","volume":"18","author":"Seitz","year":"2023","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.cobme.2026.100682_bib39","doi-asserted-by":"crossref","first-page":"9778","DOI":"10.1021\/acs.nanolett.3c02449","article-title":"A self-immolative DNA nanogel vaccine toward cancer immunotherapy","volume":"23","author":"Hu","year":"2023","journal-title":"Nano Lett"},{"key":"10.1016\/j.cobme.2026.100682_bib40","article-title":"In situ vaccination with an injectable nucleic acid hydrogel for synergistic cancer immunotherapy","volume":"63","author":"Wang","year":"2024","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cobme.2026.100682_bib41","article-title":"Tetrahedral framework nucleic acid based multifunctional nanocapsule for tumor prophylactic mRNA vaccination","volume":"34","author":"Liu","year":"2023","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.cobme.2026.100682_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/ange.202301147","article-title":"Precise epitope organization with self-adjuvant framework nucleic acid for efficient COVID-19 peptide vaccine construction","volume":"135","author":"Shen","year":"2023","journal-title":"Angew Chem"},{"key":"10.1016\/j.cobme.2026.100682_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202300308","article-title":"Tuning CpG motif position in nanostructured DNA for efficient immune stimulation","volume":"19","author":"Tan","year":"2024","journal-title":"Biotechnol J"},{"key":"10.1016\/j.cobme.2026.100682_bib44","doi-asserted-by":"crossref","first-page":"13513","DOI":"10.1021\/jacs.1c07240","article-title":"DNA dendrons as agents for intracellular delivery","volume":"143","author":"Distler","year":"2021","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cobme.2026.100682_bib45","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215091120","article-title":"Molecular DNA dendron vaccines","volume":"120","author":"Distler","year":"2023","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cobme.2026.100682_bib46","article-title":"Synthesis with control of DNA nanoflowers towards biomedical applications","volume":"32","author":"Maarifa","year":"2025","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.cobme.2026.100682_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202201518","article-title":"DNA nanomaterials-based platforms for cancer immunotherapy","volume":"7","author":"Tian","year":"2023","journal-title":"Small Methods"},{"key":"10.1016\/j.cobme.2026.100682_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adp3680","article-title":"mRNA compartmentalization via multimodule DNA nanostructure assembly augments the immunogenicity and efficacy of cancer mRNA vaccine","volume":"10","author":"Guo","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.cobme.2026.100682_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102061","article-title":"A DNA-polymer hybrid nanocomplex based Bi-Adjuvant vaccine for tumor immunotherapy","volume":"54","author":"Li","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.cobme.2026.100682_sref50","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aeb0452","article-title":"Dual-receptor targeting of type I dendritic cells with DNA-Scaffolded nanoparticles enhances STING-licensed antitumor immunity","volume":"12","author":"Jana","year":"2026","journal-title":"Sci Adv"},{"key":"10.1016\/j.cobme.2026.100682_bib51","article-title":"A multi-functional nanoadjuvant coupling manganese with toll-like 9 agonist stimulates potent innate and adaptive anti-tumor immunity","volume":"11","author":"Liu","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.cobme.2026.100682_bib52","doi-asserted-by":"crossref","first-page":"10504","DOI":"10.1021\/jacs.4c18511","article-title":"Manganese-driven plasmid nanofibers formed in situ for cancer gene delivery and metalloimmunotherapy","volume":"147","author":"Li","year":"2025","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cobme.2026.100682_bib53","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in Oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat Rev Drug Discov"}],"container-title":["Current Opinion in Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468451126000346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468451126000346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:33:30Z","timestamp":1792010010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468451126000346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":53,"alternative-id":["S2468451126000346"],"URL":"https:\/\/doi.org\/10.1016\/j.cobme.2026.100682","relation":{},"ISSN":["2468-4511"],"issn-type":[{"value":"2468-4511","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design considerations for potent DNA-platform-based cancer vaccines","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Biomedical Engineering","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cobme.2026.100682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100682"}}